Psychiatry & Neurology Doctors in Hermosa Beach, CA Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Dr. Steven Tudor Charles, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2200 Pacific Coast Hwy, Hsuite 304a, Hermosa Beach, CA 90254 Phone: 310-529-9307    Fax: 626-572-2120

Sonia Parikh, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 703 Pier Ave Ste B187, Hermosa Beach, CA 90254 Phone: 310-692-9997    Fax: 310-903-5861

Elizabeth Ellen Cowart, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2615 Pacific Coast Hwy Ste 217, Hermosa Beach, CA 90254 Phone: 310-908-1083

Barry Louis Edelman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2200 Pacific Coast Hwy Ste 304a, Hermosa Beach, CA 90254 Phone: 310-713-3180

Dr. Amir Ettekal, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1200 Artesia Blvd Ste 204, Hermosa Beach, CA 90254 Phone: 310-281-3365

News Archive

ESAOTE launches MyLab™Gamma at European Society of Cardiology 2014

Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.

CLC bio, AROS partner to provide 'Total Genomic Solutions'

Today, CLC bio announced its collaboration with one of the premier European service providers, GLP and GCP certified AROS Applied Biotechnology who specialize in Total Genomic Solutions, covering all steps from extraction, sample banking, and analysis, to advanced bioinformatics using CLC bio's enterprise platform.

ReShape Medical initiates IDE clinical study to assess effectiveness of dual-balloon device for weight loss

ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.

Poll: Many older adults are not fully prepared for emergency situations

Most people over age 50 say they're ready for natural disasters and emergency situations, but a new national poll shows that many haven't taken key steps to protect their health and well-being in case of severe weather, long-term power outages or other situations.

Read more Medical News

› Verified 7 days ago